Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the page footer; this is an administrative version change with no changes to study content.SummaryDifference0.0%

- Check19 days agoChange DetectedRemoved related topic links for Non-alcoholic fatty liver disease and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page’s related topics section.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded: a new Lancet article citation for Efimosfermin BOS-580 (2026). Deleted: older related topics entry and an earlier Lancet preprint citation.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision on the page updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics. These enhancements improve discoverability and provide additional context without altering study data or core content.SummaryDifference0.1%

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.